Home › Learn › Urolithin A vs Probiotics: Two Different Jobs in the Gut

Urolithin A vs Probiotics: Two Different Jobs in the Gut

Published 2026-09-16 · Last reviewed 2026-09-16 · By Andy Palenzuela, Founder

"Gut health" has become one phrase for at least three different things: the bacteria living in your gut, the compounds those bacteria make, and the cells that form the gut wall itself. Probiotics address the first. Urolithin A belongs to the second — and its main job is downstream of the gut entirely, in your mitochondria.

This article lays out what each one is, where it acts, what the human research has measured, and why "urolithin A vs probiotics" is the wrong frame for a choice that is really about two different problems. It is written by the founder of Age Revive, who spent 14+ years inside regulated nutrition supply chains before formulating CELLUBIOME.

Key facts

  • A probiotic: is a live microorganism that, taken in adequate amounts, is intended to confer a benefit. Effects are strain-specific and most strains do not permanently colonize.
  • Urolithin A: is not a bacterium and is not found in food. It is a metabolite that certain gut bacteria produce from ellagitannins (pomegranate, berries, walnuts). Only a portion of people carry the bacteria that do this efficiently.
  • Where each acts: probiotics act in the gut lumen while they are present. Urolithin A is absorbed and studied for its role in mitophagy — the recycling of worn-out mitochondria — throughout the body.
  • Human research on urolithin A: (Andreux 2019; Singh 2022) tested the compound at 500 mg and 1,000 mg daily and measured mitochondrial biomarkers. Neither trial tested a finished supplement.
  • They are not substitutes: One adds organisms. The other supplies a molecule those organisms may or may not be making for you.
  • CELLUBIOME: is not a probiotic. It pairs 500 mg urolithin A with 500 mg enteric-coated tributyrin.

What a probiotic is — and is not

A probiotic is a live microorganism. The widely used definition, from a 2001 FAO/WHO expert panel, is "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host." Two words in that definition do the work: live and adequate.

Three things about probiotics that the category's marketing tends to skip:

Effects are strain-specific. A benefit shown for one strain of Lactobacillus rhamnosus does not transfer to a different strain of the same species, let alone to "probiotics" as a group. "50 billion CFU" tells you a count, not what any of those organisms were studied for.

Most strains are transient. Supplemental strains typically pass through rather than take up permanent residence. Whatever they do, they do while they are there, which is why probiotic protocols are continuous.

They act in the lumen. Probiotics work inside the gut tube — competing with other microbes, producing compounds, interacting with the immune tissue in the gut wall. They do not travel to your muscle cells.

None of that makes probiotics useless. It makes them a specific tool for a specific layer: the resident microbial community.

What urolithin A is — and where it actually works

Urolithin A is a small molecule, not an organism. You cannot eat it directly. When you eat pomegranate, berries, or walnuts, you consume ellagitannins, which your gut converts to ellagic acid, which specific gut bacteria then convert to urolithins. Urolithin A is the one that has drawn the most research attention.

The catch, and the reason it exists as a supplement at all: the bacteria that perform this conversion are unevenly distributed. Research suggests most people's microbiomes do not do it efficiently, and the amount produced varies widely from person to person. Two people can eat the same pomegranate and end up with very different urolithin A levels — one of them close to zero.

Once produced (or supplied directly), urolithin A is absorbed. It is studied for its role in supporting mitophagy: the cellular process that identifies damaged mitochondria and recycles them so healthier ones can take their place. Mitochondria are in nearly every cell in the body, which is why urolithin A research measures muscle tissue and blood markers, not stool.

Strict definitions of "postbiotic" vary, and urolithin A is sometimes grouped under that label because it is a microbial metabolite. The label matters less than the practical point: urolithin A does not depend on live bacteria colonizing you. It supplies the end product directly.

Urolithin A vs probiotics at a glance

ProbioticsUrolithin A
What it isLive microorganismsA microbial metabolite (small molecule)
Where it actsGut lumen, while presentAbsorbed; studied in mitochondria system-wide
What it depends onStrain, dose (CFU), viability at time of useNothing microbial — supplied directly
Primary research focusDigestive and immune interactions, strain by strainMitophagy and mitochondrial biomarkers
Human trial doses (whitelisted)Strain-specific; not comparable500 mg and 1,000 mg/day (Andreux 2019; Singh 2022)
Does it address the gut wall's own cells?Indirectly, via microbial activityNot directly — that is a different molecule's job (see below)
Replaces the other?NoNo

What the human research on urolithin A measured

Two trials are worth knowing.

Andreux 2019 (Nature Metabolism) was a randomized, double-blind, placebo-controlled trial in 60 sedentary older adults aged 61 to 85. Participants took 250, 500, or 1,000 mg of urolithin A daily, or placebo, for 28 days. The primary endpoint was safety and tolerability, and urolithin A was reported as well tolerated at every dose. Exploratory measures included plasma acylcarnitines, which decreased, and a mitochondrial gene-expression signature in skeletal muscle at the 500 mg and 1,000 mg doses.

Singh 2022 (Cell Reports Medicine) was a randomized, placebo-controlled trial in middle-aged adults who took 500 mg or 1,000 mg of urolithin A daily for four months. The authors reported changes in muscle-strength and exercise-performance measures and in mitochondrial-health biomarkers versus placebo.

Both trials tested urolithin A as a single compound. Neither included tributyrin, and neither tested any finished supplement — including CELLUBIOME. The 500 mg dose in CELLUBIOME was chosen to align with the doses studied in this research, not because the product itself has been through a trial.

The layer most gut products skip: the barrier and the engine

If probiotics are the microbial community and urolithin A is the mitochondrial signal, there is a third layer in between that most gut formulas never mention: the gut wall itself.

The colon lining is made of cells (colonocytes) whose primary fuel is butyrate, a short-chain fatty acid produced when bacteria ferment fiber. Supporting gut-barrier integrity means supporting those cells, and that is a different molecule from either a probiotic or urolithin A.

CELLUBIOME was built around the two layers probiotics do not reach. Each serving of two enteric-coated capsules contains 500 mg of urolithin A to support mitochondrial renewal through the mitophagy pathway, and 500 mg of tributyrin — a butyrate triglyceride designed to survive stomach acid — to support colonocyte function and gut-barrier integrity. Not just gut. Mitochondria too. The reasoning behind the pairing is covered in Urolithin A + Tributyrin: Gut Barrier and Mitochondrial Support, and the delivery decision in Tributyrin vs Sodium Butyrate.

What the research does not show

  • Urolithin A is not a probiotic replacement, and probiotics are not a urolithin A replacement. They are studied for different things.
  • No trial has compared urolithin A against a probiotic, and no trial has tested them together.
  • Urolithin A does not "clean out" mitochondria or "reverse" anything. It is studied for its role in supporting mitophagy. The human data are biomarker and tolerability data at 500–1,000 mg over 4 weeks to 4 months.
  • Neither is a treatment. Supporting gut-barrier integrity or mitochondrial renewal is a structure/function description, not a claim about any digestive or muscular condition.
  • CELLUBIOME was not tested in any of the studies cited. The ingredients were.

Can you take urolithin A and a probiotic together?

There is no published evidence for or against combining them, and no known mechanism by which one would interfere with the other — they act on different layers. Whether a probiotic belongs in your routine is a question about which strain, for what, and that is worth asking a clinician rather than a label. Urolithin A does not require a probiotic to work, because it does not depend on your bacteria at all.

Frequently asked questions

Is urolithin A a probiotic? No. A probiotic is a live microorganism. Urolithin A is a small-molecule metabolite that certain gut bacteria produce from ellagitannins in foods like pomegranate. Supplemental urolithin A supplies the compound directly, whether or not your microbiome makes it.

What does urolithin A do that probiotics do not? Urolithin A is absorbed and studied for its role in supporting mitophagy — mitochondrial renewal — in tissues throughout the body. Probiotics act inside the gut while they are present. Neither does the other's job.

Should I take urolithin A or a probiotic for gut health? They address different layers. Probiotics add organisms to the gut community. Urolithin A supplies a metabolite for mitochondrial support. If gut-barrier support is the goal, that is a third layer — butyrate for the colon's own cells — which is why CELLUBIOME pairs urolithin A with tributyrin.

Is CELLUBIOME a probiotic? No. CELLUBIOME contains no live cultures. It pairs 500 mg urolithin A with 500 mg enteric-coated tributyrin to support the gut-mitochondria axis.

Sources

  1. Andreux PA, Blanco-Bose W, Ryu D, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism. 2019;1:595–603. doi:10.1038/s42255-019-0073-4. PMID 32694802.
  2. Singh A, D'Amico D, Andreux PA, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. 2022;3(5):100633. doi:10.1016/j.xcrm.2022.100633. PMID 35584623.
  3. FAO/WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Expert Consultation Report, 2001 (definition of "probiotic").

Related reading

  • What Is Urolithin A? Mitophagy, Your Microbiome, and What Human Trials Measured — Urolithin A is a gut-derived metabolite studied for supporting mitophagy, the process cells use to recycle worn-out mitochondria.
  • Urolithin A + Tributyrin: Gut Barrier and Mitochondrial Support — Urolithin A has a human study behind it; tributyrin is a butyrate delivery choice. What Andreux 2019 measured and why CELLUBIOME is not a probiotic.
  • How to Choose a Urolithin A Supplement: The Six-Check Label Test — Six checks that separate real urolithin A supplements from precursors and trace-dose products, from studied dose and purity to price.
  • The Gut-Mitochondria Axis: Why Your Gut Lining and Your Cellular Engine Run on the Same Loop — Most "gut health" products describe the gut as a tube full of bacteria and stop there.

CELLUBIOME product page · Science · FAQ · All Learn articles

About the author

Andy Palenzuela is the founder of Age Revive and has 14+ years of experience in regulated nutrition supply chains, including manufacturing oversight, ingredient sourcing, and quality assurance for consumer health products. Age Revive formulas are developed based on published peer-reviewed research and manufactured at cGMP-certified facilities. LinkedIn

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information in this article is for educational purposes only and is not intended as medical advice. Consult your healthcare provider before starting any supplement regimen.